Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Susmeeta Tewari Sharma (Tewari), MD

LICENSE # 0101245594
 
Issue Date: 5/4/2009
Expiration Date: 11/30/2024
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 10/10/2022
None Reported
Academic Appointments - Non-US
Last Updated 10/10/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 10/10/2022
Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
Best Practice & Research: Clinical Endocrinology & Metabolism
Volume: 20
Date: 06 2006
www.bprcem.com/issues/contents?issue_key=S1521-690X(06)X0031-3

Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
Gynecological Endocrinology
Volume: 22
Date: 11 2006
www.gynecologicalendocrinology.org/

Insulin Resistance and Early Pregnancy Loss in Polycystic Ovary Syndrome
BOOK: “Insulin Resistance and Polycystic Ovary Syndrome: Pathogenesis, evaluation, and treatment
Book Chapter
Date: 06 2007
books.google.com/

Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis.
Endocrine Practice
Volume: 13
Date: 07 2007
aace.metapress.com/app/home/main.asp?referrer=default

The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
BOOK: Diagnosis and Management of Polycystic Ovary Syndrome
Book Chapter : 10
Date: 02 2009
www.springerlink.com/content/p1261136102mu742/

Cushing's syndrome: all variants, detection, and treatment
Endocrinol Metab Clin North Am
Volume: 40
Date: 06 2011
www.ncbi.nlm.nih.gov/pubmed/21565673

Prolactin as a marker of successful catheterization during IPSS in patients with ACTH-dependent Cushing's syndrome
Journal of Clinical Endocrinology and Metabolism
Volume: 96
Date: 12 2011
www.ncbi.nlm.nih.gov/pubmed/22031511

Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion
European Journal of Endocrinology
Volume: 166
Date: 03 2012
www.ncbi.nlm.nih.gov/pubmed/22190002

Physiological Basis for the Etiology, Diagnosis,and Treatment of Adrenal Disorders: Cushing’s Syndrome, Adrenal Insufficiency, and Congenital Adrenal Hyperplasia
Comprehensive Physiology
Volume: 4
Date: 04 2014
Compr Physiol 4:739-769, 2014.

An individualized approach to the evaluation of Cushing Syndrome
Endocrine Practice
Volume: 23
Date: 01 2017
Endocr Pract. 2017 Jun;23(6):726-737. doi: 10.4158/EP161721.RA